Erythropoiesis-stimulating agents--time for a reevaluation. 2010

Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D006397 Hematinics Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. Erythropoiesis Stimulating Agent,Hematinic,Hematopoietic Agents,Erythropoiesis Stimulating Agents,Agent, Erythropoiesis Stimulating,Stimulating Agent, Erythropoiesis
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068256 Darbepoetin alfa A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA. Aranesp,Aranest,Darbepoietin alfa,KRN 321,KRN-321,KRN321,NESP,Novel Erythropoiesis Stimulating Protein
D000068817 Epoetin Alfa A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients. Binocrit,Epoetin Alfa Hexal,Epogen,Eprex,HX575,HX575 Compound,Heberitro,Procrit,Recombinant 1-165 Erythropoietin, Glycoform Alpha,Alfa Hexal, Epoetin,Alfa, Epoetin,Compound, HX575,Hexal, Epoetin Alfa,Recombinant 1 165 Erythropoietin, Glycoform Alpha
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
March 2007, BMJ (Clinical research ed.),
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
November 2011, Therapeutische Umschau. Revue therapeutique,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
January 2011, Cancer treatment and research,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
April 2010, Nature reviews. Nephrology,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
May 2010, The New England journal of medicine,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
May 2010, The New England journal of medicine,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
May 2010, The New England journal of medicine,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
July 2013, Journal of the National Cancer Institute,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
May 2007, AIDS clinical care,
Ellis F Unger, and Aliza M Thompson, and Melanie J Blank, and Robert Temple
May 2010, Journal of oncology practice,
Copied contents to your clipboard!